Now Approved
for Advanced Parkinson’s Disease

VYALEV delivers
24 HOURS OF CONTINUOUS
LEVODOPA-BASED THERAPY
morning, day, and night

SUPERIOR
“ON” TIME
VS PILLS*

DOES NOT
REQUIRE
SURGERY

REPLACES YOUR
LEVODOPA
PILLS

 

*VYALEV was studied against oral immediate-release carbidopa/levodopa pills. At week 12, patients taking VYALEV achieved 2.72 hours more “On” time vs 0.97 hours more “On” time for those taking levodopa pills.

VYALEV replaces levodopa-containing medications and catechol-O-methyltransferase (COMT) inhibitors. If required, other Parkinson's disease medications can be taken with VYALEV. Keep a supply of oral immediate-release carbidopa/levodopa tablets with you in case you are unable to use VYALEV infusion.

DESIGNED for people with Parkinson’s disease

VYALEV delivers levodopa-based therapy under the skin through a wearable pump—all day and all night.

VYALEV™ Pump.
  • Large buttons and clear display
  • Wearable in multiple ways
    with a range of carrying case options
  • Can be temporarily disconnected
    for up to 1 hour for water-based activities, such as swimming or showering

Do not use or wear the pump while doing any activity that could cause liquids to get onto or into the pump. Some of these activities include taking a bath or shower, or swimming.

Keep a supply of oral immediate-release carbidopa/levodopa tablets with you in case you are unable to use VYALEV infusion.

Refer to the Patient Pump Instructions for Use for details on disconnecting and reconnecting the pump https://www.rxabbvie.com/pdf/vyalev_pat_vyafuserpump.pdf.

Only use VYALEV by yourself after you have been shown the right way to use VYALEV.

The VYALEV Pump is small, lightweight (10 oz), and approximately the size of 2 stacked cell phones

VYALEV™ pump.
VYALEV™ Pump.

Ask your

doctor about VYALEV

VYALEV™ Complete logo.

VYALEV Complete is a Patient Support Program that provides one-on-one guidance every step of the way at no additional cost. 

Be among the first to receive news and updates about VYALEV

Read about the VYALEV approval in advanced Parkinson’s treatment